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Previously, we reported the development of two fibroblastic cell lines (MDV OU2.1 and OU2.2) infected with Marek’s
disease virus (MDV). The two cell lines, in nonconfluent continuous cultures, displayed characteristics consistent with MDV
existing in a latent state. However, presence of distinct plaques in confluent cell monolayers and the ability to transfer
cytolytic infection to susceptible birds and primary chick embryo fibroblasts, suggest that, if latent, the virus is easily
reactivated from MDV OU2 cell lines. In this report, we present evidence which supports the hypothesis that MDV genomes
in MDV OU2 cells are latent. PCR analyses and in vivo experiments demonstrate that CHCC-OU2 cells stabilize MDV so
that serial in vitro passage does not attenuate the virus. Following two years of active culture, MDV genomes in MDV OU2
cells are still oncogenic, similar to that seen in MDV-lymphoblastoid cell lines. Expansion of the 132-bp repeat within MDV
BamHI fragments H and D, typical of highly passaged serotype 1 MDV, has not been observed beyond two copies in MDV
OU2 cells. Indirect immunofluorescence assays clearly demonstrate that MDV OU2 cells do not express glycoproteins B
and I when subconfluent. However, upon reaching confluence these proteins are expressed in readily detectable amounts.
Using RT-PCR we demonstrate that glycoproteins E and D are highly expressed in confluent MDV OU2 cells but absent
from subconfluent cells, and MDV latency-associated transcripts (LATs), which are antisense to ICP4 transcripts and have
been associated with latent MDV infection, are expressed in subconfluent MDV OU2 cells. Coincident with an increase in
ICP4 expression, MDV LAT expression is down regulated when MDV OU2 cells become confluent. q 1997 Academic Press
INTRODUCTION lines have been isolated and established from MD tumors
(Schat et al., 1991; Akiyama and Kato, 1974; Powell et al.,
Marek’s disease (MD) is a lymphoproliferative disease
1974; Calnek et al., 1978; Payne et al., 1981; Nazarian and
of chickens caused by Marek’s disease virus (MDV). MDV
Witter, 1975). MDV-transformed lymphoblastoid cells are
is an avian herpesvirus, which is highly infectious and cell
immortalized cell lines which are latently infected with MDV
associated (Calnek and Witter, 1991). In infected birds, a
and usually capable of transferring MDV to CEF or DEF in
lytic cycle of MDV replication takes place in differentiating
vitro and to susceptible chickens in vivo.
epithelial cells and bursal lymphocytes. Infectious viruses
In MDV lymphoblastoid cell lines a limited set of viral
are produced only in feather follicle epithelium and are
genes have been found to be transcribed (Maray et al.,
shed with feather dander and dust (Witter et al., 1972; Cal-
1988; Sugaya et al., 1990). Transcriptional activity is lim-
nek et al., 1970). Following an initial burst of lytic infection,
ited to approximately 20% of the MDV genome, primarily
T-lymphocytes become latently infected with MDV. Subse-
in repeat regions and adjacent sequences. Most tran-
quently, chickens infected with virulent, oncogenic (sero-
scripts found in MDV lymphoblastoid cells are derived
type 1) strains of MDV develop aggressive T-cell lympho-
from immediate early (IE) genes (Silver et al., 1979; Schat
mas (Calnek and Witter, 1991). Evidence accumulated to
et al., 1989), suggesting that IE genes could have a signif-
date suggests that latent infection of T-lymphocytes is a
icant role in maintenance of latency. Latency-associated
prerequisite to malignant transformation and neoplastic dis-
transcripts (LATs) which map antisense to IE genes have
ease (Shek et al., 1983).
been described for many herpesviruses. Transcripts anti-
Although MDV cannot produce fully infectious particles
sense to ICP4 have been reported for pseudorabies virus
(enveloped virus) in tissue culture, cytopathic infections can
and have been postulated to be involved in latency (Priola
be produced in monolayers of primary or secondary
et al., 1990). In the case of herpes simplex virus, LATs
chicken and duck embryo fibroblasts (CEF and DEF, re-
map antisense to the ICP0 gene (Feldman, 1991).
spectively) as well as chick kidney cells (CKC). CEF, CKC,
Epstein – Barr virus (EBV) latently infects human B-
and DEF support the lytic cycle of MDV in vitro (Schat et
lymphocytes, causing both benign and malignant
al., 1989). In addition, more than 90 lymphoblastoid cell
lymphoproliferations. Viral gene expression during la-
tent infection is limited to 11 viral genes, 9 of which
are translated. Six of these proteins are nuclear (Ep-1 To whom reprint requests should be addressed.
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stein – Barr nuclear antigen (EBNA)-1, -2, -3A, -3B, -3C, exists in a continuous latent state in MDV OU2 cell lines
and virus lytic cycle is activated upon confluency. Virus-LP), and three latent membrane proteins (LMP)-1,
-2A, -2B) (Lee, 1994). Reactivation of EBV replication produced from MDV OU2 cell lines remained virulent
and oncogenic after more than 30 in vitro passages. Inis induced by ZEBRA (an immediate-early activator en-
coded by BZLF1 gene) (Countryman and Miller, 1985). addition, continuous cultivation in CHCC-OU2 cells ap-
pears to stabilize MDV genomes. For approximately 2BZLF1 is a transcription factor that can activate other
viral genes and also affect cellular genes (Flemington years of continuous culture, only a minor expansion of
an unstable 132-bp DR sequence (het region) was de-and Speck, 1990). In MDV, LATs which map antisense
to ICP4 have been detected (Li et al., 1994; Cantello tected in MDV OU2 cells. Our results suggest the MDV
OU2 cell system may represent an ideal in vitro systemet al., 1994; Mckie et al., 1995). These LAT transcripts
appear to be expressed at higher levels in lymphoblas- to study factors involved in the switch between lytic and
latent herpesvirus infections. In addition, stabilization oftoid cell lines (MSB-1 and RPL1) and are down regu-
lated in lytically infected cells (Li et al., 1994). Although MDV genes will have important applications in produc-
tion of recombinant and mutant MDV.it is possible that MDV LATs play a role in maintenance
of latency, definitive evidence is still lacking.
MDV can be rescued from some lymphoblastoid cell MATERIALS AND METHODS
lines by cocultivation with primary or secondary CEF and
Cells and virusDEF (Schat et al., 1989). In addition, some lymphoblastoid
cell lines will induce MD upon injection into susceptible Preparation, propagation, and infection of CEF cells
birds (Akiyama et al., 1973, Nazarian et al., 1977). Reacti- with MDV were performed as described previously (Glau-
vation of cytolytic infection, however, varies with each biger et al., 1983; Coussens and Velicer, 1988). The very
cell line. virulent MDV strain Md11 was used at cell culture pas-
Serial in vitro passage of virulent oncogenic MDV re- sage levels 15, 28, 35, 48, and 86 (Md11p15, Md11p28,
sults in loss of MDV tumorigenicity (Churchill and Chubb, Md11p35, Md11p48, and Md11p86, respectively). CHCC-
1969). Attenuation of MDV was strongly correlated with OU2 (Ogura and Fujiwara, 1987), MDV OU2.2, and MDV
an expansion in two regions (BamHI-H and -D), present OU2.1 cells were maintained as described previously
in MDV long terminal repeat (TRL) and long inverted re- (Abujoub and Coussens, 1995). MDV OU2 cells were
peat (IRL) regions, respectively (Silva and Witter, 1985; used at cell culture passages 8, 12, 16, 23, and 31 (MDV
Fukuchi et al., 1985; Chen and Velicer, 1991). It was latter OU2.2p8 , MDV OU2.2p12, MDV OU2.2p16, MDV
discovered that expansion was due to amplification of a OU2.2p23, and MDV OU2.2p31) for PCR, and RT-PCR
132-bp direct repeat (DR) sequence found within MDV analyses . MDV OU2.1 and OU2.2 cells are passaged
BamHI-H and -D fragments (Maotani et al., 1986). Tumor every 10–15 days prior to formation of confluent mono-
induction studies in susceptible birds suggest that layers.
cloned virus populations which exhibit an amplification
of the 132-bp repeat region have decreased tumorigenic Preparation of cellular DNA and polymerase chain
capability. In contrast, viruses which do not contain am- reaction (PCR)
plified BamHI-H or -D regions efficiently induce tumors
in chickens (Fukuchi et al., 1985). Total cellular DNA was extracted from CEF, CEF/Md11,
MSB-1, CHCC-OU2, and MDV OU2 cells by standardRecently we reported development of fibroblastic cell
lines (MDV OU2.1 and OU2.2) infected with serotype 1 methods (Sambrook et al., 1989). Total cellular DNA was
used as a template for PCR amplification of the 132-bpMDV, strain Md11 (Abujoub and Coussens, 1995). MDV
OU2 cell lines are similar to certain lymphoblastoid cell DR sequences. The upstream primer (5*-TGCGATGAA-
AGTGCTATGGAGG-3*) anneals 3-bp 5* to the 132-bp DRlines that MDV infection can be transferred to primary
and secondary CEF monolayer culture and MD induced sequences, while the downstream primer (5*-GAGAAT-
CCCTATGAGAAAGCGC-3*) anneals 6 bp from the 3* endin susceptible birds (Abujoub and Coussens, 1995). How-
ever, MDV OU2 cell lines, unlike lymphoblastoid cell of the 132-bp DR sequences. PCR using these two prim-
ers amplifies a 317-bp fragment when two copies of thelines, are not transformed.
Latency in many viruses results from lack of host fac- DR sequence are present (Silva, 1992). PCR conditions
were slightly modified from those suggested by Silvators critical for the expression of viral IE gene products
(Garcia-Blanco and Cullen, 1991). Reactivation of these (1992). Briefly, 200 ng of total cellular DNA was mixed
with 20 mM of each dNTP , 20 mM of each oligonucleotideviruses from the latent state is not completely under-
stood, but could be due to activation of specific cellular primer pair, 10 ml 101 PCR reaction buffer (Life Technolo-
gies, Gaithersburg, MD), 1.5 mM MgCl2 , and 1.0 U Taqfactors in response to an external stimuli. Stimulation will
activate viral regulatory proteins and lead to a state of polymerase (Life Technologies). PCR reactions were per-
formed using a GeneAmp 9600 thermal cycler (Perkin –lytic infection. As a first step in examining the status of
MDV in the MDV OU2 cell lines, we report here that MDV Elmer–Cetus, Norwalk, CT). Following an initial denatur-
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ing step at 957 for 5 min, DNA was amplified during 25 727 for 15 min. A negative control without template and
a positive control with Md11p35 DNA was included incycles of 957 for 30 sec, 677 for 30 sec, and 727 for 30
sec. PCR reactions were completed by a final elongation each RT-PCR reaction. PCR conditions for glycoproteins
D and E were similar to those of MDV ICP4 and LATs,step at 727 for 10 min. A negative control with CHCC-OU2
DNA was included in each PCR reaction. Amplification of except for using 10 mM of oligonucleotide primers D1 and
D2 (5*-TACGTGAATATGCCAACTGC-3*) as an upstreaman 850-bp fragment of the pp38 gene was performed as
previously described (Abujoub and Coussens, 1995). primer and oligonucleotide primers E1 and E2 (5*-GAA-
TCGCTAAGTCTGAATGG-3*) as an upstream primer, re-PCR products were analyzed on 6% polyacrylamide gels,
stained with ethidium bromide, and photographed under spectively. Also, the annealing temperature has been
changed to 567 to match the Tm of these oligonucleotideultraviolet light. Sizes of amplified fragments were deter-
mined by comparison to a 1-kb DNA ladder marker (Life primers.
Technologies).
Inoculation of chickens with cells and virus
RNA isolation and reverse transcriptase PCR In vivo experiments were performed using specific
(RT-PCR) pathogen-free chickens (SPF), obtained from SPAFAS
(Chicago, IL). Chicks were divided into three groups of
Total RNA was isolated from CHCC-OU2, MDV
5 chicks per group at 1 day of age, and groups inoculated
OU2.2p31, Md11p35, and MSB-1 cells using the Trizole
intraperitoneally with: (A) 2.0 1 106 uninfected CHCC-
reagent (Life Technologies) according to the manufactur-
OU2 cells, (B) 2000 plaque forming units (PFU) of MDV
er’s recommendation. Prior to use, RNA was treated with
OU2.2p8 cells, or (C) 2000 PFU of MDV OU2.2p23.
10 units RNase-free RQ1 DNAase (Promega, Madison,
Birds were euthanized and necropsied upon severe
WI) for 30 min at 377. Coupled cDNA synthesis and PCR
signs of morbidity. Blood was collected, and peripheral
amplification of extracted RNAs was carried out in two
blood leukocytes (PBLs) were isolated as described (Tar-
steps. First, cDNA synthesis was performed in 250 mM
def and McQueen, 1993) and cocultivated with secondary
Tris–HCl (pH 8.3), 375 mM KCl, 15 mM MgCl2 , 100 mM CEF cells as an assay for production of viable virus.
dithiothreitol, and 10 mM each dATP, dCTP, dGTP, and
Various tissues, including heart, liver, kidney, and spleen
dTTP. First strand synthesis mixture also contained 0.5
were frozen for subsequent DNA isolation. Total tissue-
U RNasin (Promega), 200 U Superscript II Reverse Tran-
specific (Kidney) DNA was isolated and used as template
scriptase (Life Technologies), and 15 mg of total cellular
for PCR amplification of the 132-bp DR sequence and for
RNA. One micromolar of oligonucleotide corresponding
an 850-bp region of MDV pp38 gene sequences.
to nt 411–435 (complementary) of M49 cDNA clone of
MDV (Li et al., 1994) (5*-CGTCGGACATGTTTCCAGATC- Indirect immunofluorescence antibody (IIFA) staining
GCC-3*) was used as a downstream primer in order to
amplify MDV LATs transcripts, whereas 1 mM of oligonu- Uninfected CEF, CEF infected with Md11p15, CHCC-
OU2, and MDV OU2.2 cells, grown on glass cover slipscleotide corresponding to nt 98–122 of M49 cDNA clone
of MDV (Li et al., 1994) (5*-CGTTGGACGGCTCGGCGG- in 35-mm tissue culture plates, were used for indirect
immunofluorescence labeling according to standard pro-ACTTGGG-3*) was used as a downstream primer to
amplify ICP4 transcripts. Oligonucleotide primers D1 (5*- tocols ( Harlow and Lane, 1988; Hong et al., 1995). CEF
and CHCC-OU2 cells were processed 3 days postplatingAGTGAGTCCAGTGTAAACCATCC-3*) and E1 (5*-CAG-
AATGTCAATGTTGGATGCG-3*) were used as down- on cover slips. CEF infected with Md11p15 were pro-
cessed 1 day after displaying plaques characteristic ofstream primers to amplify glycoproteins D and E tran-
scripts, respectively. Reactions were incubated at 427 for MDV infection. MDV OU2.2 were processed either when
they were 60–80% confluent (subconfluent) or 5 days60 min, followed by enzyme inactivation for 15 min at
707. Second, the cDNA synthesized in the first step was after forming a confluent monolayer (confluent). Cells
were washed with cold PBS, fixed and permeabilizedused as a template for PCR reaction as follows: 10% of
the first strand reaction was amplified in 200 mM Tris – with 2 ml of ice-cold acetone:methanol (1:1) for 3 min at
room temperature with gentle agitation. Following threeHCl (pH 8.4), 500 mM KCl , 1.5 mM MgCl2 , 20 mM of
each dNTP, and 10 mM each of oligonucleotide corre- washes with cold PBS, cells were preincubated with 3%
BSA in PBS for 1 hr at room temperature. Anti-MDV/gBsponding to nt 98–122 of M49 cDNA clone of MDV and
nt 411–435 (complementary) (Li et al., 1994) for ampli- (Silva and Lee, 1984) monoclonal antibody ( generously
provided by Dr. Lucy Lee, USDA-ADOL) was added tofying MDV LATs and MDV ICP4. PCR reactions were
performed using a GeneAmp 2400 thermal cycler (Per- the cells at a 1:40 dilution in PBS and incubated for 1 hr
at room temperature. Anti-MDV/gI polyclonal antibodykin–Elmer–Cetus). Following an initial denaturing step
at 957 for 5 min, DNA was amplified during 30 cycles of (generously provided by Dr. Lee Velicer, Department of
Microbiology, Michigan State University) was added to957 for 45 sec, 627 for 45 sec, and 727 for 45 sec. PCR
reactions were completed by a final elongation step at cells in a 1:20 dilution in PBS and incubated for 1 hr
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at room temperature. After extensive washing with PBS, respectively). Similarly, anti-MDV/gI (Brunovskis, and Vel-
icer, 1995) polyclonal antibodies detected a protein con-sheep anti-mouse IgG (whole molecule) conjugated with
fluorescein-5*-isothiocyanate (FITC) (Sigma) was used as sistent with MDV gI in confluent MDV OU2.2p16, but not
in subconfluent cells (Figs. 3D and 3B, respectively). Asecondary antibody for cells incubated with anti-MDV/
gB as primary antibody. Goat anti-rabbit IgG (whole mole- similar protein was not detected in either subconfluent
or confluent CHCC-OU2 cells (A and C in Figs. 2 and 3).cule) conjugated with FITC (Sigma, St. Louis, MO) was
used as a secondary antibody for cells incubated with Uninfected CEF and Md11p15/CEF cells were used as
negative and positive controls, respectively (data notanti-MDV/gI as a primary antibody. All secondary anti-
bodies were diluted 1:20 in PBS. After extensive washing shown). Together, results of IIFA staining, Western blot
analysis (Abujoub and Coussens, 1995), and MDV OU2with PBS, Slow-Fade (Molecular Probes, Eugene, OR)
was added prior to mounting to glass slides to minimize cell growth characteristics suggest that fully lytic growth
of MDV and corresponding expression of late proteinsquenching of fluorescence. Cells were photographed on
an Olympus BH-2 fluorescence microscope. is initiated only after MDV OU2 cells form a confluent
monolayer.
RESULTS
Detection of late structural glycoproteins expression
MDV is stably maintained in subconfluent using RT-PCR
MDV OU2 cells
RT-PCR was used to compare MDV gene expression
Recently we reported development of two fibroblastic between subconfluent and confluent MDV OU2 cells. Oli-
cell lines (MDV OU2.2 and OU2.1) capable of supporting gonucleotide primers specific for glycoproteins E and D
replication and growth of MDV (Abujoub and Coussens, amplified 530- and 560-bp fragments, respectively, from
1995). MDV OU2 cells cannot be visibly distinguished confluent MDV OU2 cells but not from subconfluent MDV
from uninfected parental CHCC-OU2 cells when grown OU2 cells (Figs. 4A and 4B). A similar pattern of expres-
at a subconfluent level ( Figs. 1A and 1B). Subconfluent sion was detected in MD11p35 lytically infected CEF
MDV OU2.2 cells do not display any signs of lytic MDV cells and no expression was detected in uninfected
infection and exhibit a doubling time only slightly shorter CHCC-OU2 cells (Figs. 4A and 4B). No expression of gD
than parental cells. Within 5 days of becoming confluent, was detected in MSB-1 cells but very low level of gE
monolayers of MDV OU2 cells display plaques similar in expression was detected. This low level of expression
appearance to those observed in MDV-infected primary may be due to the spontaneous viral reactivation within
or secondary CEF cells (Figs. 1C and 1D). Thus MDV MSB-1 cells.
OU2 cells have been viable in cell culture for almost 2
years and display plaques only when allowed to reach MDV LATs are expressed in subconfluent
confluence. MDV OU2 cells
Within MDV OU2 cells, MDV may exist in a latent state
We used RT-PCR to determine if antisense ICP4and is reactivated when cells become confluent. Alterna-
mRNA’s could be detected in MDV OU2 cell lines undertively, cytolytic infection of CHCC-OU2 cells by MDV may
subconfluent and confluent conditions. Total cellular RNAbe offset by cellular growth in subconfluent cultures. In
isolated from CHCC-OU2 cells, MDV-OU2 cells (subcon-this case, plaques become visible only when contact
fluent and confluent), MSB-1 cells, and Md11p35/CEFinhibition decreases cellular growth. To distinguish be-
cultures was used for RT-PCR to detect expression oftween these possibilities, the nature of MDV infection in
MDV LATs. A 335-bp fragment corresponding to the 5*MDV OU2 cells was examined.
end of M49 cDNA which maps antisense to the MDV
ICP4 gene (Li et al., 1994) was detected in RNA isolatedDetection of viral proteins by IIFA staining
from subconfluent MDV OU2 cells, MSB-1 cells, and oc-
casionally in confluent MDV OU2 cells, but was not de-MDV OU2 cells express pp38 and pp14 in quantities
sufficient to be detected by Western blot analysis (Abu- tected in RNA isolated from lytically infected Md11p35/
CEF or uninfected CHCC-OU2 cells (Fig. 5A). A fragmentjoub and Coussens, 1995). However, expression of other
MDV antigens, particularly those of structural glycopro- of approximately 230 bp amplified during RT-PCR of
MSB-1 cells RNA may represent an alternatively splicedteins, was not detectable by Western blot analysis (Abu-
joub and Coussens, 1995). Therefore, we compared MDV variant of MDV LATs (Fig. 5A, lane 6).
To verify that products amplified in RT-PCR reactionsantigen expression by IIFA staining of subconfluent and
confluent MDV OU2 cells. Anti-MDV/gB (Silva and Lee, were indeed antisense to the MDV ICP4 homolog gene,
PCR products were transferred to a Zeta-probe mem-1984) monoclonal antibody IAN 86 ( generously provided
by Dr. Lucy Lee, USDA-ADOL) detected a protein consis- brane and probed with DNA corresponding to the MDV
ICP4 gene. Hybridization of radioactively labeled MDVtent with MDV gB in confluent MDV OU2.2p16, but not
in subconfluent MDV OU2.2p16 cells (Figs. 2D and 2B, ICP4 probes to RT-PCR products from reaction with MDV
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OU2 and MSB-1 RNA (Fig. 5C) confirmed that these prod-
ucts were located within the ICP4 gene. No hybridization
was detected in lanes containing RT-PCR reactions with
CHCC-OU2 or Md11p35 RNA (Fig. 5C). As a control for
DNA contamination, no hybridization was detected when
RNA templates were used for PCR without prior addition
of Superscript II Reverse Transcriptase (data not shown).
There was no hybridization of ICP4-specific probe to the
230-bp band in LAT-specific or ICP4-specific RT-PCR re-
actions with MSB-1 RNA(Fig. 5A, lane 6), or to the 175-
bp band in Md11p35/CEF and MSB-1 (Fig. 5B, lanes 5
FIG. 5. RT-PCR amplification of a 335-bp fragment of MDV LATs
and ICP4 gene. (A) LAT-specific primers were used to amplify a
335-bp fragment using total RNA isolated from CHCC-OU2 (lane 2),
Md11p35/CEF (lane 3), confluent MDV OU2.2p31 (lane 4), subcon-
fluent MDV OU2.2p31 (lane 5), MSB-1 cells (lane 6). Lanes 7 and 8
are PCR negative and positive control, respectively. (B) Primers spe-
cific for the MDV ICP4 transcript were used for RT-PCR amplification
of a 300-bp fragment using RNA isolated from CHCC-OU2 (lane 4),
Md11p35/CEF (lane 5), confluent MDV OU2.2p31(lane 6), subcon-
fluent MDV OU2.2p31 (lane 7), MSB-1 cells (lane 8). Lanes 2 and 3
represent PCR negative and positive controls, respectively. A 1-kb
DNA ladder marker (Life Technologies) (lane 1) was used for size
comparison. Numbers at the left indicate approximate sizes of ampli-
fied fragments. Smaller size fragments are due to nonspecific ampli-
fication and were not detected using Southern blot analysis (data
not shown). (C) Southern blot hybridization of LATs RT-PCR. Using
ICP4 gene as a probe, RT-PCR products from MSB-1 and Subcon-
fluent MDV OU2 cell strongly hybridized to a product of the expected
size. No hybridization was detected in lanes containing uninfected
OU2, confluent MDV OU2 cells, and Md11p35/CEF.
and 8), suggesting these bands represented nonspecific
amplification products. Expression of MDV LATs in MDV
OU2 cells combined with MDV protein expression pat-
terns strongly suggest that MDV is in a latent state in
these cells. Down regulation of MDV LATs in confluent
MDV OU2 cells is associated with an increase in ICP4
gene expression as deduced from RT-PCR results (Fig.
FIG. 4. RT-PCR amplification of a 530-bp fragment of gE and of a 5B, compare lanes 6 and 7). MDV ICP4 gene expression
560-bp fragment of gD transcripts. (A) Glycoprotein E-specific primers
in subconfluent MDV OU2 cells was very low compared(E1 and E2) were used to amplify a 530-bp fragment using total RNA
to expression in Md11p35-infected CEF cells and conflu-isolated from uninfected CHCC-OU2, Md11p35/CEF, confluent MDV
OU2.2p33, MSB-1, and subconfluent MDV OU2.2p33 cells. (B) Glycopro- ent MDV OU2 cells (Fig. 5B, lanes 5 and 6). These results
tein D-specific primers were used to amplify a 560-bp fragment using are consistent with previous evidence that ICP4 tran-
total RNA isolated from uninfected CHCC-OU2, Md11p35/CEF, conflu- scripts are predominantly expressed in lytically infected
ent MDV OU2.2p33, MSB-1, and subconfluent MDV OU2.2p33 cells.
cells and antisense transcripts are predominantly pro-PCR-negative control was used in all reactions ( No Template lane). A
duced in latently infected cells (Cantello et al., 1994; Li1-kb DNA ladder marker (Life Technologies) was used for size compari-
son. Numbers at the left indicate sizes of MW marker fragments. et al., 1994).
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sequence in MDV DNA was not significantly expanded
following extended serial in vitro passage in MDV OU2
cells. In contrast, and as expected, the 132-bp DR region
was expanded following serial in vitro passage in sec-
ondary CEF cells. Therefore, similar to lymphoblastoid
cell lines, MDV OU2 cells appear to stabilize MDV DNA.
Despite many years in culture, lymphoblastoid cell lines
are still capable of inducing MD in susceptible birds.
Upon PCR analysis, 3–5 copies of the 132-bp DR se-
quences (data not shown) were detected in MDV ge-
nomes from MSB-1 cells. To further verify stabilization of
MDV het region DNA in MDV OU2 cells, an equal pas-
sage variant of Md11 was generated in CEF cells. Due
to a switch in passage numbering upon transfer to the
CHCC-OU2 culture system, Md11p48/CEF represents an
equal number of passages as MDV OU2.2p28 cells. A
comparison of equal passage MDV in MDV OU2 cells
(MDV OU2.2p28) and CEF cells (Md11p48) (Fig. 6B, lanes
3 and 2, respectively) clearly demonstrated that the 132-
bp DR sequence is stabilized within MDV OU2 cells (Fig.
6B, lane 3) relative to an equal passage counterpart culti-FIG. 6. PCR amplification of the 132-bp DR sequence. (A) DNA iso-
vated on CEF cells (Fig. 6B, lane 2). More than sevenlated from CHCC-OU2 (lane 2), Md11p15/CEF (lane 3), MDV OU2.2p12
(lane 4), MDV OU2.2p23 (lane 5), and Md11p86/CEF (lane 6) was used copies of the 132-bp DR were detected in PCR amplifica-
as template for PCR amplification. A 1-kb ladder marker (Life Technolo- tion (Fig. 6A, lane 6, and Fig. 6B, lane 2) of DNA from CEF
gies) (lane 1) was used for size comparison. DNA isolated from CHCC- cells infected with Md11p86 and Md11p48, respectively.
OU2 cells (lane 2) served as negative control. (B) DNA isolated from
Md11p15/CEF (lane 1), Md11p48/CEF (lane 2), and MDV OU2.2p28
(lane 3) was used as template for PCR amplification of DR sequences. High passage MDV OU2 cells induce MD in
Numbered arrows at the right indicate number of copies of the 132- susceptible chickens
bp DR sequence. Arrows at the left represent positions of selected
bands from the 1-kb ladder marker (Life Technologies). Early passages of MDV OU2.2 cells can induce MD in
susceptible birds within 3–5 weeks following intraperito-
neal injection (Abujoub and Coussens, 1995). Stabiliza-Serial in vitro passage does not cause attenuation of
tion of het region DNA in MDV OU2 cells suggested that,MDV genomes in MDV OU2 cells
as with MDV lymphoblastoid cells, MDV pathogenicity
should also be preserved in long term cultures of MDVA PCR assay developed by Silva (1992) was used to
estimate the number of 132-bp DR sequences present OU2 cells. To confirm that the MDV genomes were not
attenuated after extended serial in vitro culture in MDVin MDV genomes following serial in vitro passage of MDV
OU2 cells and various control infections. Two hundred OU2 cells, SPF chickens were inoculated with either
MDV OU2.2p8 (low passage) or p23 (high passage) cellsnanograms of total DNA from CHCC-OU2, Md11p15/CEF,
Md11p28/CEF, Md11p48/CEF, Md11p86/CEF, MDV at 1 day of age. As a negative control, chickens were
injected with parental CHCC-OU2 cells. Consistent withOU2.2p12, MDV OU2.2p23, and MDV OU2.2p28 cells was
used as template for PCR amplification with a primer previous results, chickens injected with MDV OU2.2p8
cells developed classical signs of MD by the end of theset flanking the 132-bp DR sequence (het region). In all
reactions, except the CHCC-OU2 negative control, it was fourth week postinoculation and either died or had to be
euthanized by the end of the fifth week due to widespreadpossible to detect a 185-bp amplified fragment corre-
sponding to one copy of the 132-bp DR (Fig. 6A, lane 3). paralysis. Necropsy revealed complete bursal atrophy
and splenomegaly in all birds inoculated with MDVA 317-bp fragment corresponding to two copies of the
132-bp DR was predominant in reactions containing OU2.2p8. Chickens inoculated with MDV OU2.2 p23 also
displayed signs of MD within 3–5 weeks postinoculation.pathogenic Md11p15/CEF DNA as well as in DNA iso-
lated from MDV OU2.2p12 and p23 (Fig. 6A, lanes 3, 4, In addition to severe paralysis, birds inoculated with
MDV OU2.2p23 cells displayed severe weight loss whenand 5). Although the 317-bp fragment was present in
DNA amplified from cells infected with Md11p86, the compared to CHCC-OU2- and MDV OU2.2p8-injected
birds (data not shown). All birds in this group were eu-predominant PCR products were distributed over a range
of bands representing between four and seven copies thanized by the end of the fifth week due to signs of
severe illness. Upon necropsy, complete bursal atrophyof the 132-bp DR sequence (Fig. 6A, lane 6).
Results of PCR analyses indicated that the 132-bp DR and early signs of tumor formation were observed in
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primed with a primer set specific for pp38 gene se-
quences amplified an 850-bp fragment in reactions con-
taining DNA isolated from kidneys of birds inoculated
with MDV OU2.2p8 (Fig. 7B, lanes 4 and 5) or MDV
OU2.2p23 (Fig. 7B, lanes 6 and 7). No detectable MDV
products were amplified in reactions containing DNA
from kidneys of birds inoculated with CHCC-OU2 (Figs.
7A and 7B, lanes 2 and 3). The presence of MDV-specific
PCR products indicated that both MDV OU2.2p8 and
MDV OU2.2p23 cells were capable of transferring MDV
to susceptible birds.
As an additional test for disseminated viremia in in-
fected birds, blood was collected at the time of euthaniza-
tion, and peripheral blood leukocytes (PBLs) were iso-
lated from whole blood, washed with PBS, and coculti-
vated with secondary CEF cells. CEF monolayers
cocultivated with PBLs from MDV OU2.2p8 and p23-in-
jected birds displayed plaques consistent with MDV in-
fection 3–5 days postcultivation. In contrast, and as ex-
pected, no plaques were observed on CEF monolayers
FIG. 7. PCR amplification of an 850-bp MDV pp38 gene. (A) DNA cocultivated with PBLs from chickens injected with
isolated from kidneys of birds inoculated with CHCC-OU2 (lanes 2 and
CHCC-OU2 cells. The disseminated viremia is an indica-3), MDV OU2.2p8 (lanes 4 and 5), and MDV OU2.2p23 (lanes 6 and 7)
tion that MDV OU2 cells induced a systematic MDV infec-was used as template for PCR amplification of the 132-bp DR region
as described under Materials and Methods. DNA isolated from tion in the inoculated birds and the virus was not local-
Md11p15 and p28/CEF (lanes 8 and 9) served as positive controls for ized to the site of inoculation (intraperitoneal cavity).
DNA isolation and PCR reaction. (B) DNA isolated from kidneys of birds
inoculated with CHCC-OU2 (lanes 2 and 3), MDV OU2.2p8 (lanes 4
and 5), and MDV OU2.2p23 (lanes 6 and 7) was used as template for DISCUSSION
PCR amplification of 850 bp as described under Materials and Meth-
ods. DNA isolated from Md11p15 and p28/CEF (lanes 8 and 9) served The MDV strain Md11-infected fibroblastic cell lines
as positive controls for DNA isolation and PCR reaction. A 1-kb ladder MDV OU2.1 and OU2.2 (Abujoub, and Coussens, 1995)
marker (Life Technologies) (lane 1) was used for size comparisons. are permissive for MDV replication. In contrast with pri-
Sizes of selected fragments are indicated at the left.
mary CEF and DEF, these cell lines have an unlimited
life span and have been in continuous culture for 2 years
under conditions similar to that used for primary fibro-livers of dissected birds. In contrast, chickens inoculated
with parental CHCC-OU2 cells showed no clinical signs blasts. Growth characteristics and appearance of MDV
OU2 cells are indistinguishable from the parental CHCC-of MD. Control birds inoculated with CHCC-OU2 cells
were euthanized at 16 weeks postinoculation. Necropsy OU2-immortalized fibroblastic cell line (Ogura and Fuji-
wara, 1987). MDV OU2 cells display characteristics con-revealed no signs of bursal atrophy, splenomegaly, or
tumor formation. sistent with MDV genomes existing in a latent state, simi-
lar to that observed in MD-lymphoblastoid cell lines.To confirm that injected birds harbor MDV genomes,
total cellular DNA isolated from kidneys was used as However, the appearance of distinct plaques in confluent
cell monolayers is more consistent with a lytic infectiontemplate for PCR amplification using a primer set specific
for the 132-bp DR sequence (Silva, 1992) and for amplifi- (Abujoub, and Coussens, 1995). Thus, MDV OU2 cells
appear to ‘‘switch’’ from a latent to lytic infection, coinci-cation of an 850-bp segment of the pp38 gene (Abujoub
and Coussens, 1995). No PCR products were detected dent with cells reaching confluence. Both MDV OU2 cell
lines are capable of transferring MDV infection to CEFwhen DNA isolated from two separate control bird kid-
neys was used as template (Fig. 7A, lanes 2 and 3). in culture and inducing clinical signs of MD in suscepti-
ble birds. Virus yields from these cell lines is comparableIn contrast, amplification products consistent with MDV
sequences containing two to four copies of the 132-bp to or greater than yields produced by CEF cultures. Thus,
CHCC-OU2- and MDV-infected derivatives provide an ex-DR sequence were amplified from MDV OU2.2p8-inocu-
lated bird kidneys (Fig. 7A, lanes 4 and 5). PCR reactions cellent system for cultivation of MDV vaccine viruses,
production of MDV mutants (with coordinated expressionusing DNA isolated from MDV OU2.2p23-injected birds
resulted in amplification of products consistent with two of essential genes), and a model for herpesvirus latency/
reactivation.to five copies of the 132-bp DR sequence (Fig. 7A, lanes
6 and 7). Md11p15/CEF DNA was used as a positive The overall aims of this study were to determine the
status of MDV genomes in MDV OU2 cells and to exam-control for PCR reactions (Fig. 7A, lane 8). PCR reactions
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TABLE 1 that MDV LATs may serve to down regulate expression
of MDV ICP4.Summary of IIFA and RT-PCR Results
The factors responsible for the switch from a latent
Expressed gene state in subconfluent cultures to a lytic infection in conflu-
ent monolayers is not understood. Generally, factors im-
Cell type gB gI gD gE ICP4 LATs portant in determining latent or lytic infection cycles in
many herpes viruses are cellular activators or repressorsMSB-1 ND ND 0 { / //
which in turn activate or repress viral gene productsMd11/CEF // // // // // 0
Subconfluent MDV OU2 0 0 0 0 { // responsible for determining the pathway of viral infection
Confluent MDV OU2 // // // // // { (Garcia-Blanco and Cullen, 1991). MDV OU2 cells are
CHCC-OU2 0 0 0 0 0 0 similar to their parental CHCC-OU2 cells in being contact
inhibited. It is possible that changes in cell growth asso-Note. ND, not determined; {, low level of expression; /, normal
ciated with confluence and contact inhibition act to trig-level of expression; //, high level of expression; 0, not detected.
ger reactivation of MDV leading to expression of the full
complement of MDV genes and lytic replication. It is
tempting to speculate that such a trigger may be a regu-ine the effect of in vitro passage on stability of MDV
genomes and virus pathogenesis within MDV OU2 cells. lator (repressor) of MDV LAT expression. As in CEF cells,
lytic replication of MDV in confluent MDV OU2 cell cul-To achieve our first goal, we used IIFA staining and RT-
PCR to examine differential gene expression in subcon- tures appears to be of the productive restrictive class
with no infectious virions released into the culture fluidfluent versus confluent MDV OU2 cells. Our results, sum-
marized in Table 1, support the hypothesis that MDV (Abujoub and Coussens, unpublished observations)
Serial in vitro passage of virulent MDV strains on CEFis in a latent state in MDV OU2 cells, similar to MDV
lymphoblastoid cell lines. IIFA staining and RT-PCR data cells results in attenuation and loss of oncogenicity
which is correlated with het region expansion. In thisclearly demonstrate that expression of structural glyco-
proteins (glycoproteins B, I, D, and E) which are encoded report, we provide evidence that a highly variable MDV
genome region is stabilized in MDV OU2 cells, and afterby late genes and are mainly expressed in lytically in-
fected cells, occurs only in confluent cell monolayers. over 2 years of continuous in vitro culture MDV from MDV
OU2 cells is still oncogenic. PCR analyses showed thatThis pattern of protein expression is consistent with MDV
genomes existing in a latent state in subconfluent MDV the number of 132-bp DR sequences did not change
significantly in MDV genomes after more than 30 in vitroOU2 cells. MDV appears to be reactivated and a full cycle
of lytic infection initiated after cells reach confluence. passages. Whereas, Md11 passed in CEF culture for
the same number of passages (Md11p48/CEF) exhibitedCantello et al. (1994) and Li et al. (1994) separately
reported the identification of transcripts (MDV LATs) that significant expansion of the 132-bp DR region. The num-
ber of 132-bp DR sequences in oncogenic MDV strainsmap antisense to the ICP4 homolog gene of MDV. MDV
LATs are expressed at a significantly higher level in is typically between 2 and 5 copies, whereas the average
number in strains attenuated by in vitro cultivation onlymphoblastoid cell lines (MSB-1 and RPL1) than in lyti-
cally infected cells. Based on these findings, it was spec- CEF cells is three to greater than seven copies. These
results suggest that, as with MDV lymphoblastoid cellulated that MDV LATs may play a role in maintenance
of latency by negatively regulating MDV ICP4 expression lines MDV OU2 cell lines tend to stabilize the MDV ge-
nome. However, CHCC-OU2 cells are nontumorigenic(Cantello et al., 1994; Li et al., 1994). Using RT-PCR, we
examined the level of expression of MDV LATs in MDV and thus may offer an attractive alternative for production
of recombinant MDV which may be unstable in CEF cul-OU2 cells from subconfluent cultures versus confluent
cultures. Expression of MDV LATs in subconfluent MDV tures.
Marek’s disease can be induced by injection of MDV-OU2 cells was comparable to that observed in MSB-1
cells. MDV LAT expression is down regulated when cells infected cells into susceptible birds. Tumor incidence
can reach 100%, but is dependent on various natural andbecome confluent and was not detected or detected at
a very low levels when cells were allowed to display experimental conditions and factors, for example, virus
strain and dose, site of injection, age at primary expo-plaques characteristic of lytic MDV infection. When the
level of MDV ICP4 expression was examined, the level sure, and the genetic background of the birds (Calnek
and Witter, 1991). Oncogenic serotype 1 MDV-infectedof ICP4 expression was inversely proportional to the level
of MDV LAT expression. The similarity between MDV CEF, DEF, and CKC cells as well as some producer MD-
lymphoblastoid cell lines such as MSB-1, CU36, andLAT/ICP4 expression patterns in subconfluent MDV OU2
cells to MSB-1 cells strongly supports our hypothesis CU41 are able to induce MD in susceptible birds. Simi-
larly, MDV OU2 cells are capable of inducing MD inthat MDV exists in a latent state in MDV OU2 cells in
subconfluent cultures. In addition, our results confirm the susceptible birds. With serial in vitro passage, in CEF,
DEF, and CKC cells oncogenic MDV strains are rapidlyhypothesis of Cantello et al. (1994) and Li et al. (1994)
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